Results 11 to 20 of about 59 (57)

Somatic Mutational Landscape of Hereditary Hematopoietic Malignancies Associated with Germline Variants in RUNX1, GATA2 and DDX41

open access: yes, 2022
Germline variants in RUNX1, GATA2 and DDX41 may confer a predisposition to hereditary haematopoietic malignancies (HHMs) such as MDS and AML yet have distinct age ranges of malignancy diagnosis and a highly variable overall risk for leukemogenesis.
Lawrence, D.   +20 more
core   +1 more source

Integrated personalized prediction model identifies a subgroup of wild-type tp53therapy-related myeloid neoplasm patients with poor outcome

open access: yes, 2022
Background: Therapy-related myeloid neoplasm (t-MN), is a heterogenous entity that includes therapy-related myelodysplastic syndromes (t-MDS), myelodysplastic syndrome/myeloproliferative neoplasms (t-MDS/MPN), and acute myeloid leukemia (t-AML ...
Chhetri, R.   +4 more
core   +1 more source

Haemogenic Gastruloids Recapitulate Developmental Haematopoiesis and Provide an Ontogeny-Relevant Context to Dissect the Origins of Infant Leukemia [PDF]

open access: yes, 2022
Meeting abstract presented at the 64th ASH Annual Meeting and Exposition, New Orleans, LA, USA, 10-13 Dec 2022..Modelling of developmental hematopoiesis has historically been challenging due to the inability to produce hematopoietic stem cells (HSC) and ...
Ragusa, D   +13 more
core   +1 more source

Machine Learning Improves Risk Stratification in Myelofibrosis: An Analysis of the Spanish Registry of Myelofibrosis

open access: yes, 2022
20.500.12530 ...
Velez Tenza, Patricia   +31 more
core   +1 more source

Real-World Data Analysis of the Molecular Response Kinetics within the Two First Years of the RELMC-NOVA Study in Newly Diagnosed Spanish CML-CP Patients Treated with Tirosin Kinasa Inhibitors (TKIs) in First Line

open access: yes, 2022
20.500.12530 ...
Casado Montero, Luis Felipe   +19 more
core   +1 more source

Thrombotic and bleeding complications in patients with chronic lymphocytic leukemia and severe COVID-19: a study of ERIC, the European Research Initiative on CLL [PDF]

open access: yes, 2022
Patients with chronic lymphocytic leukemia (CLL) may be more susceptible to COVID-19 related poor outcomes, including thrombosis and death, due to the advanced age, the presence of comorbidities, and the disease and treatment-related immune deficiency ...
Allsup, David   +130 more
core   +1 more source

Easix Application in Adults Undergoing Allogeneic Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide-Based Prophylaxis

open access: yes, 2022
20.500.12530 ...
Martinez Munoz, Maria Carmen   +21 more
core   +1 more source

Protection Against Breakthrough Delta/Omicron Variants in Vaccinated Patients with Myeloproliferative Neoplasms (MPN)

open access: yes, 2022
20.500.12530 ...
Foncillas, Maria Angeles   +61 more
core   +1 more source

Liver Toxicity As Dose Limiting Toxicity of Bosutinib in Combination with Atezolizumab in Chronic Myeloid Leukemia. Results from the Phase Ib/II Zerolmc Trial

open access: yes, 2022
20.500.12530 ...
Teresa Gomez-Casares, Maria   +11 more
core   +1 more source

Immunoparesis Recovery in Transplant-Ineligible Newly Diagnosis Multiple Myeloma Patients: An Independent Prognosis Factor That Could Complement Prognostic Value of Minimal Residual Disease

open access: yes, 2022
20.500.12530 ...
San-Miguel, Jesus   +35 more
core   +1 more source

Home - About - Disclaimer - Privacy